Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Neuroenhancement through cognitive training and anodal tDCS in multiple sclerosis.
Expression of cathepsins S and D signals a distinctive biochemical trait in CD34+ hematopoietic stem cells of relapsing-remitting multiple sclerosis patients.
Administration of monthly-pulse cyclophosphamide in multiple sclerosis patients. Effects of long-term treatment on immunologic parameters.
Calpain inhibition attenuated morphological and molecular changes in skeletal muscle of experimental allergic encephalomyelitis rats.
ISMRM Workshop on Multiple Sclerosis as a Whole-Brain Disease
A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis.
Dalfampridine may activate latent trigeminal neuralgia in patients with multiple sclerosis.
Long-term safety and efficacy of teriflunomide: Nine-year follow-up of the randomized TEMSO study.
Long-term adherence of patients with relapsing-remitting multiple sclerosis to subcutaneous self-injections of interferon β-1a using an electronic device: the RIVER study.
The unidimensional self-efficacy scale for MS (USE-MS): developing a patient based and patient reported outcome.
Validation of a Dutch version of the Neurological Fatigue Index (NFI-MS) for patients with multiple sclerosis in the Netherlands.
The AusD Study: A Population-based Study of the Determinants of Serum 25-Hydroxyvitamin D Concentration Across a Broad Latitude Range.
Recurrent Nicolau syndrome associated with subcutaneous glatiramer acetate injection-a case report.
The ketogenic diet as a treatment paradigm for diverse neurological disorders.
The potential role of epigenetic modifications in the heritability of multiple sclerosis.
LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex.
Laquinimod for multiple sclerosis.
RebiSmart™ (version 1.5) device for multiple sclerosis treatment delivery and adherence.
Differential glatiramer acetate treatment persistence in treatment-naive patients compared to patients previously treated with interferon.
A Network Meta-Analysis of Efficacy and Evaluation of Safety of Subcutaneous Pegylated Interferon Beta-1a versus Other Injectable Therapies for the Treatment of Relapsing-Remitting Multiple Sclerosis.
Multiple sclerosis.
Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases.
Metabolomics of cerebrospinal fluid reveals changes in the central nervous system metabolism in a rat model of multiple sclerosis.
Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis.
Double Blind Combination of Rituximab by Intravenous and Intrathecal Injection Versus Placebo in Patients With Low-Inflammatory Secondary Progressive Multiple Sclerosis (RIVITaLISe)

Pages